Since the onset of the coronavirus pandemic, some companies have been trying to do their part in helping the world get back to some sense of normalcy. As scientists speculate on the possibility COVID-19 becomes another recurring disease humans learn to live with, much like the flu, delivery giant UPS says it's committed to the continued safe distribution of vaccines around the world.
"The world is now vaccinating roughly six million people a day. That'll be 5.4 years before we get to 75 percent of the world's population," Scott Price, head of international operations for UPS, told Cheddar.
"What I can tell you is that given the size and the scope of the world's population and in our network, we're always going to be prepared for the capacity needs to get this vaccine around the world," he added.
The company's services aren't just limited to the needs of the United States. While the AstraZeneca vaccine has not been cleared for use in the U.S., UPS has worked closely with other countries, South Korea in particular, in distribution efforts. Price said the company is willing to transport any vaccine to any place in need.
UPS Healthcare and the UPS Foundation have also donated $3 million to COVID vaccination efforts.
"Distribution is really critical when it comes to vaccines. We've been doing healthcare distribution. We have a pretty substantial segment, but you know the ultra-low temperature required on these vaccines is what makes this one particularly unique," Price said. "Now, we have cold storage capability, so as part of our donation, that $3 million, part of it is just capacity of that ultra-low temperature."
With the company delivering nearly 25 million packages every day, Price said UPS has "plenty of capacity" to ensure the safe delivery of vaccines worldwide.
"We have to continue to drive solutions in manufacturing so that we're able to get these into the arms of citizens around the world," he explained.
Shan Aggarwal, VP of Corporate and Business Development at Coinbase, discusses the company's acquisitio of Deribit as it heads into the S&P 500. Watch!
American businesses that rely on Chinese goods are reacting with muted relief after the U.S. and China agreed to pause their exorbitant tariffs on each other’s products for 90 days. Many companies delayed or canceled orders after President Donald Trump last month put a 145% tariff on items made in China. Importers still face relatively high tariffs, however, as well as uncertainty over what will happen in the coming weeks and months. The temporary truce was announced as retailers and their suppliers are looking to finalize their plans and orders for the holiday shopping season. They’re concerned a mad scramble to get goods onto ships will lead to bottlenecks and increased shipping costs.
Shopping expert Trae Bodge discusses how talks between the U.S. and China is good news for now, but uncertainty remains for back-to-school and the holidays.
Jake Traylor, White House reporter at Politico, joins Cheddar to discuss how Trump is aiming to lower drug prices and how it differs from Biden's approach.
DJ X, alongside Molly Holder, Senior Director of Product Personalization, takes us inside Spotify's A.I. DJ and how it's the best new way to listen to music.
Sheryl Palmer, CEO of Taylor Morrison, talks tariff uncertainty, being a female leader in a male dominated industry and what homebuyers need to know. Watch!
